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InactivationThe human ether-à-go-go related gene potassium channel is a key player in cardiac rhythm regulation, thus
being an important subject for a cardiac toxicity test. Ever since human ether-à-go-go related gene channel
inhibition-related cardiac arrest was proven to be fatal, numerous numbers of data on human ether-à-go-
go related gene channel inhibition have been piled up. However, there has been no quantitative study on
human ether-à-go-go related gene channel inhibition by quaternary ammonium derivatives, well-known
potassium channel blockers. Here, we present human ether-à-go-go related gene channel blockade by
externally applied quaternary ammonium derivatives using automated whole-cell patch-clamp recordings
as well as ab initio quantum calculations. The inhibitory constants and the relative binding energies for
human ether-à-go-go related gene channel inhibition were obtained from quaternary ammoniums with
systematically varied head and tail groups, indicating that more hydrophobic quaternary ammoniums have
higher afﬁnity blockade while cation-π interactions or size effects are not a deterministic factor for human
ether-à-go-go related gene channel inhibition by quaternary ammoniums. Further studies on the effect of
quaternary ammoniums on human ether-à-go-go related gene channel inactivation implied that
hydrophobic quaternary ammoniums either with a longer tail group or with a bigger head group than
tetraethylammonium permeate the cell membrane to easily access the high-afﬁnity internal binding site in
human ether-à-go-go related gene channel and exert stronger blockade. These results may be informative
for the rational drug design to avoid cardiac toxicity.82 2 958 5189.
ll rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
The human ether-à-go-go related gene (hERG) voltage-gated
potassium channels play an essential role in cardiac rhythm
regulation, in particular responsible for repolarization of the cardiac
action potentials [1–3]. When hERG channels are blocked, repolariz-
ing cardiac potassium currents are reduced, causing the prolonged
cardiac action potential. This phenomenon is called the drug-induced
long QT syndrome, characterized by prolongation of the QT interval in
the electrocardiogram and leading to the fatal cardiac arrhythmia
[4,5]. Assessment of drug candidates against hERG channels has thus
been required for US- and EU-FDA approvals.
Most of drugs exhibiting hERG channel inhibition share a basic
nitrogen atom with additional hydrophobic groups in their core
structure [6], which implies the importance of cation interactions
and hydrophobicity in channel blockade. Particularly, a tertiary
amine group on blockers is likely to be protonated mostly at
physiological pH, which resembles a quaternary ammonium (QA), a
well-known potassium channel blocker. Among QAs, tetraethylam-monium (TEA) is the classical potassium channel blocker, whose
blockade mechanism has been extensively investigated. Externally
applied TEA binds to a site within the external mouth of the
channel, and this binding region determines external TEA sensitivity
of potassium channels [7]. Shake potassium channels have been well
studied as a model system for investigation of TEA afﬁnity at the
molecular level, revealing that aromatic residues are responsible for
producing high-afﬁnity TEA blockade [8], suggesting the signiﬁcant
role of π-electrons.
Among voltage-gated potassium channels, hERG potassium chan-
nels have been scrutinized for drug safety assessment. hERG channels,
however, have not been rigorously tested for QA inhibition, although a
few seminal experiments on hERG channel inhibition by QAs were
reported [9,10]. Systematic studies on hERG channel blockade by
various QAs would thus be valuable given the signiﬁcance of hERG
channels in drug discovery. In the present work, recombinant hERG
channels heterologously expressed in Chinese hamster ovary cells
were examined using automated patch clamp, where four indepen-
dent patch-clamp recordings are carried out in parallel. A series of QA
blockers with various head and tail groups were tested to study the
quantitative structure–activity relationship and the underlying
mechanism of hERG channel inhibition. The present study demon-
strates that hydrophobicity is a main factor to determine high-afﬁnity
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or size effects.
2. Material and methods
2.1. Cell culture and preparation
CHO-K1 cells expressing hERG channels via the inducible Tet-On
gene expression system (CHO-K1 Tet-On hERG cells) were purchased
from IonGate Biosciences GmbH (Frankfurt, Germany). CHO-K1 Tet-
On hERG cells were cultured in Dulbecco's modiﬁed Eagle's medium
containing 10% (vol./vol.) fetal bovine serum, penicillin (100 U/ml),
streptomycin (100 μg/ml), fungizone (2.5 μg/ml) as well as selection
antibiotics, geneticin G418 (200 μg/ml), hygromycin (200 μg/ml), and
puromycin (2 μg/ml) in humidiﬁed 5% CO2 at 37 °C. Cells were
passaged every three days by trypsin–EDTA treatment. For hERG
channel expression, the Tet-On gene expression was induced by
adding 5 μg/ml of doxycyclin (Sigma, St. Louis, MO, USA) into the
growthmedium. For automated patch-clamp recordings, CHO-K1 Tet-
On hERG cells were plated into the 100 mm culture dishes. Cells at
50%–80% conﬂuency were harvested by treatment with trypsin–
EDTA, washed twice, and resuspended in the extracellular solution at
a ﬁnal cell density of 1–5×106 cells per milliliter. Cells were used for
whole-cell recordings approximately 20–32 h after doxycyclin
addition.
2.2. Automated patch-clamp electrophysiology
The automated patch-clamp device, NPC-16 Patchliner (Nanion
Technologies, München, Germany) was used for whole-cell record-
ings. Automated patch-clamp devices have been successfully utilized
for cardiac toxicity tests for hERG channels [11]. A number of research
papers on assessments of hERG channel liability with automated
patch clamp have been reported [12–14], providing convincing
evidence that automated patch clamp is a reliable method to study
hERG channel inhibition. Whole-cell currents were recorded with the
intracellular solution containing (in mM) 50 KCl, 60 KF, 10 NaCl, 2
MgCl2, 20 EGTA, and 10 HEPES (pH 7.2), and with the extracellular
solution containing (in mM) 140 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 5
glucose, and 10 HEPES (pH 7.4). To assist stable seal formations, the
seal enhancer containing (in mM) 80 NaCl, 3 KCl, 35 CaCl2, 10 MgCl2,
and 10 HEPES (pH 7.4) was used only at the seal formation step. Prior
to the whole-cell recordings, the external seal enhancing solution was
exchanged to the extracellular solution described above. hERG
channel currents were recorded using the parallel EPC-10 patch-
clamp ampliﬁers (HEKA Elektronik, Lambrecht/Pfalz, Germany) and
low-pass ﬁltered (10 kHz) with a 4-pole Bessel ﬁlter. Cell suspension
and patch solutions were automatically added onto the four recording
wells in the microfabricated disposable chip (NPC-16 Chip, Nanion
Technologies, München, Germany). To obtain the inhibitory con-
stants, hERG tail currents were evoked by repolarizing steps to
−50 mV for 500 ms preceded by a 500 ms depolarization potential of
+20 mV at a holding potential of−80 mVwith a 20 s sweep interval.
To measure the inactivation rates, re-inactivating hERG channel
currents were elicited on return to +20 mV after a 30 ms pulse to
−80 mV at a holding potential of +20 mV in the absence and
presence of each QA. Whole-cell currents were acquired and digitized
at 5 kHz, and linear leak currents were subtracted employing a
standard P/−4 leak subtraction protocol [15] using the Patchmaster
(HEKA Elektronik, Lambrecht/Pfalz, Germany). Both raw and leak
subtracted data were stored. The extracellular solution was ex-
changed to the extracellular solution containing each test QA blocker
via 4 pipette tips of NPC-16 Patchliner using a 4-fold volume of
solution (40 μl) with a speed of 4 μl/s, and the exchanged blocker
solution was applied for 100–200 s to the patch-clamped cells untilblocker binding had reached equilibrium by monitoring hERG tail
currents.
2.3. Chemicals and synthesis
Tetramethylammonium chloride (TMA-Cl), tetraethylammonium
chloride (TEA-Cl), tetrapropylammonium chloride (TPA-Cl), tetra-
butylammonium bromide (TBA-Br), tetrapentylammonium chloride
(TPnA-Cl), tetrahexylammonium chloride (THxA-Cl), tetraheptylam-
monium bromide (THpA-Br), and triethylhexylammonium bromide
(C6-TEA-Br) were purchased from Sigma-Aldrich Corp. (St. Louis,
MO, USA). Triethyloctylammonium bromide (C8-TEA-Br), triethyl-
decylammonium bromide (C10-TEA-Br), triethyldodecylammonium
bromide (C12-TEA-Br), and triethyltetradecylammonium bromide
(C14-TEA-Br) were synthesized by reacting the appropriate alkyl-
bromide with triethylamine in absolute ethanol for ~3 days as
described previously [16]. Alkyl-TEA puriﬁed by recrystallization
was identiﬁed using the IR,
1
H-NMR,
13
C-NMR, and mass spectra
(available upon request).
2.4. Data analysis
Whole-cell recordings were analyzed using the Patchmaster/
Fitmaster (HEKA Elektronik, Lambrecht/Pfalz, Germany), IGOR Pro
(WaveMetrics Inc., Portland, OR, USA), and the GraphPad Prism 4
(GraphPad Software, Inc., La Jolla, CA, USA) software.
To yield concentration–response curves, the concentration–re-
sponse data were ﬁtted with a Hill equation,
% inhibition = 100= 1 + Ki = QA½ ð Þh
 
where Ki is the inhibitory constant, [QA] is concentration of QA
blocker, and h is the Hill coefﬁcient. The magnitude of QA inhibition
(percentage inhibition) was calculated as (ICTR - IQA) / ICTR, where ICTR
and IQA are the amplitude of hERG tail current before and after the
application of QA, respectively.
The time course of re-inactivating current decay was ﬁtted with a
single exponential equation,
I tð Þ = Ip⋅exp −t = τinactð Þ + Ir
where I(t) is the hERG channel re-inactivating current as a function of
time, Ip is the peak current amplitude, t is time, τinact is the inactivation
time constant, and Ir is the residual current amplitude. The
inactivation rate, kinact was deﬁned as the reciprocal of the time
constant of inactivation (1/τinact).
Relative binding energy (ΔΔG) was obtained using the following
equation,
ΔΔG = RT⋅ln Ki;X = Ki;TEA
 
where Ki,X and Ki,TEA are the inhibitory constants of other QA and TEA,
respectively. R is the gas constant and T is an absolute temperature.
2.5. Ab initio calculations of cation-π interaction energies
The cation-π interaction energies were calculated for symmetric
QA–benzene complexes using the Gaussian 03 program. For QA and
QA–benzene complexes, geometry optimization and energy calcula-
tion were carried out at the Hartree–Fock level using the 6–31 g(d,p)
basis set. The initial conﬁgurations of QA–benzene complexes for
geometry optimization were chosen based on the previously reported
ab initio calculation results [17,18]. The initial conﬁgurations were
varied by changing the distance between QA and benzene as well as
by changing the facing angle of benzene with respect to three alkyl
Fig. 1. Tetraethylammonium (TEA) inhibition of hERG channels in automated patch clamp. (A) A representative whole-cell recording of hERG channels evoked by 500 ms test pulses
to−50 mV preceded by a 500 ms depolarizing potential of +20 mV at a holding potential of−80 mV before (upper traces) and after (lower traces) leak subtraction. Whole-cell tail
currents of hERG channels were blocked by ~36% on average upon applying 30 mM TEA to the bath solution (control, 30 mM and 300 mM of TEA applied). (B) Time course of the
amplitude of hERG tail currents in response to increasing TEA concentrations of 1, 10, 30, 100, and 300 mM as shown on the top.
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searched. For a given QA–benzene complex, the cation-π interaction
energy was calculated by subtracting the energies of QA and benzene
optimized separately from the energy of the optimized QA–benzene
complex.
3. Results
3.1. hERG channel inhibition by QAs with various head and tail groups
To investigate the molecular characteristics of hERG channel
blockade by QAs, TEA, the best-known potassium channel blocker,
was initially tested on hERG channels. Whole-cell currents were
recorded from CHO-K1 cells stably expressing hERG channels with
automated patch clamp in order to obtain the inhibitory constants (Ki)
of TEA for hERG channel inhibition. hERG tail currents were evoked by
repolarizing steps to −50 mV for 500 ms preceded by a 500 ms
depolarization potential of +20 mV at a holding potential of −80 mV
as shown in Fig. 1A. On average, 30 mMTEA inhibited the tail currents ofFig. 2. hERG channel inhibition by QAs with various head and tail groups. (A) Symmetric QA
THpA. (B) Asymmetric QAs with various tail groups: □, TEA; ●, C6-TEA; △, C8-TEA; ■, C10
generated using percentage inhibition of hERG tail currents as a function of QA concentration
coefﬁcients, summarized in Table 1. Each point was pooled from at least ﬁve recordings. ThhERG channels by 36%±4% (n=14; Fig. 1A). Five concentrations of TEA
(1–300 mM)were applied to the patched cell in a cumulativemanner as
shown in the representative time trace of hERG tail currents in Fig. 1B.
Further studies on hERG channel inhibition were carried out using
QAs with systematically varied head and tail groups. To evaluate the
effect of head group, the N-substituents of symmetric QAs are varied
from the methyl group (tetramethylammonium; TMA) to the heptyl
group (tetraheptylammonium; THpA). The effect of tail group was
also examined using asymmetric QAs with various alkyl chains from
the hexyl group (triethylhexylammonium; C6-TEA) to the tetradecyl
group (triethyltetradecylammonium; C14-TEA). The inhibition of
hERG tail currents by all test QA blockers was concentration-
dependent (Fig. 2). Normalized tail current amplitudes in the
presence of QA were plotted as a function of QA concentration and
ﬁtted with a Hill equation. The Ki values and the Hill coefﬁcients (h) of
QA blockers were summarized in Table 1.
Three hundred millimolars TMA or TEA showed a more than 100%
inhibition (105%±2% for 300 mM TMA, n=6; 101%±3% for 300 mM
TEA, n=14; in Fig. 2), although it is within the experimental error ins with various head groups: ●, TMA; □, TEA; ▲, TPA; ○, TBA; ■, TPnA;△, THxA; and ◆,
-TEA; ○, C12-TEA; and ▲, C14-TEA. Concentration–response data of QA inhibition were
. The data were ﬁtted with a Hill equation to obtain the inhibitory constants and the Hill
e error bars indicate the SEM.
Table 1
Summary of the inhibitory constants (Ki) and the Hill coefﬁcients (h) of various QAs
against hERG channels obtained with automated patch clamp and the relative binding
energies (ΔΔG).
Blocker Ki (M) h n ΔΔG
(kcal/mol)
Symmetric QA TMA 6.25±0.86 (×10−2) 1.9±0.1 6 0.18
TEA 4.61±0.51 (×10−2) 1.4±0.1 14 0
TPA 7.43±0.89 (×10−3) 1.1±0.1 7 −1.06
TBA 3.52±0.64 (×10−4) 1.3±0.1 12 −2.83
TPnA 2.69±0.18 (×10−7) 1.9±0.1 7 −6.99
THxA 2.30±0.19 (×10−8) 1.5±0.2 7 −8.42
THpA 1.97±0.15 (×10−6) 1.5±0.1 13 −5.83
Asymmetric QA C6-TEA 1.71±0.17 (×10−4) 1.3±0.1 9 −3.25
C8-TEA 5.77±0.23 (×10−6) 1.9±0.1 7 −5.21
C10-TEA 1.51±0.17 (×10−6) 1.3±0.1 12 −5.99
C12-TEA 3.87±0.22 (×10−7) 1.2±0.1 10 −6.78
C14-TEA 4.03±0.56 (×10−7) 1.4±0.1 8 −6.76
The Ki and h values are given as the mean±SEM; n is the number of experiments.
Relative binding energy (ΔΔG) is calculated as ΔΔG=RT·ln(Ki,X /Ki,TEA), where RT is
0.58 kcal/mol at room temperature and X represents a blocker. TMA indicates
tetramethylammonium; TEA, tetraethylammonium; TPA, tetrapropylammonium; TBA,
tetrabutylammonium; TPnA, tetrapentylammonium; THxA, tetrahexylammonium; THpA,
tetraheptylammonium; C6-TEA, triethylhexylammonium; C8-TEA, triethyloctylammonium;
C10-TEA, triethyldecylammonium; C12-TEA, triethyldodecylammonium; C14-TEA,
triethyltetradecylammonium.
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may contribute to this observation. However, endogenous channels
are likely to be expressed at very low levels in the CHO cells compared
to hERG channels, and thus their contributions would be negligible,
which is supported by the fact that the Ki value of TEA obtained in the
present study is similar to the previously reported value [9]. A more
than 100% inhibition by the high concentrations of TMA could result
from the osmotic stress. In fact, it was often observed that the seal was
getting unstable when the patch-clamped cells were exposed to
300 mM TMA or TEA, probably due to osmotic effects. However, this
phenomenonwas not frequently observed at concentrations less than
100 mM. Thus, the Ki values (Ki of 63 mM for TMA and Ki of 46 mM for
TEA in Table 1) are unlikely to be affected by the osmotic effects.
The relative binding energies (ΔΔG) were calculated from the Ki
values using TEA as a reference (Table 1 and Fig. 3A), andwere plotted
against the number of total carbon atoms in QAs as the two separate
groups: symmetric QAs (● and solid line) and asymmetric QAs (□ andFig. 3. Relative binding energies (ΔΔG) of various QAs obtained from their inhibitory const
asymmetric QAs. Relative binding energy was calculated using an equation, ΔΔG=RT·ln(Ki,X
The ΔΔG values were plotted as a function of the number of total carbon atoms in symmetdotted line) in Fig. 3B. Symmetric QAs exhibited higher afﬁnity
blockade of hERG channels as the size of head group was increased,
and asymmetric QAs with a longer tail also showed the stronger effect
on hERG channel inhibition. These enhanced blockade effects,
however, were observed to be saturating for both symmetric and
asymmetric QAs. The ΔΔG values of asymmetric QAs approached a
value of−6.8 kcal/mol as the length of a carbon tail was increased to
the tetradecyl (C14) group. In case of symmetric QAs, the inhibition
effect started saturating at tetrahexylammonium (THxA), and THpA
produced attenuated inhibition even below tetrapentylammonium
(TPnA).
3.2. Effect of externally applied QAs on hERG channel inactivation
Symmetric QAs with a bigger head group and asymmetric QAs
with a longer tail group showed higher afﬁnity blockade against hERG
channels, suggesting the importance of hydrophobicity. Unlike
membrane-impermeable TEA, hydrophobic QA blockers might cross
the cell membrane to easily access the high-afﬁnity internal binding
site. To investigate further the mechanism of hERG channel inhibition
by hydrophobic QAs, their effect on the hERG channel inactivation
process were examined. It has been well established that C-type
inactivation of hERG channel is retarded by external QA blockers but
not by internal QA blockers [9]. To test whether externally applied
QAs interact with an external binding site or they permeate the cell
membrane to bind to a high-afﬁnity internal site, re-inactivating hERG
channel currents were elicited on return to +20 mV after a 30 ms
pulse to−80 mV at a holding potential of +20 mV in the absence and
presence of each QA. As a positive control, TEA was tested ﬁrst, and
then all other QAs were assessed. Re-inactivating hERG channel
currents were much slowly decayed in the presence of externally
applied TEA as expected (control, gray solid line; TEA, black solid line
in Fig. 4A). The inserts in Fig. 4B show the hERG channel inactivation
time courses ﬁtted with a single exponential equation (controls, gray
dotted lines; QA blockers, black dotted lines) to determine the
inactivation rates. The ratio of the inactivation rate in the absence of
QA (kinact−QA) to the inactivation rate in the presence of QA at its Ki value
(kinact+QA) is presented in Fig. 4B. Small QAs such as TMA slowed hERG
channel inactivation like TEA although its effect was about half that of
TEA. More hydrophobic QAs did not affect the hERG channel
inactivation process, indicating that QAs either with a bigger head
group or with a longer tail group than TEA do not interact with the
external binding site unlike TEA or TMA.ants (Ki). (A) The ΔΔG values were presented as the two groups: symmetric QAs and
/Ki,TEA), where RT is 0.58 kcal/mol at room temperature and X represents a blocker. (B)
ric QAs (● and solid line) and asymmetric QAs (□ and dotted line).
Fig. 4. Effect of externally applied QAs on hERG channel inactivation. (A) Re-inactivating hERG channel currents were elicited on return to +20 mV after a 30 ms pulse to−80 mV at
a holding potential of+20 mV in the absence and presence of 46 mMTEA. Re-inactivating currents were slowly decayed in the presence of externally applied TEA (control, gray solid
line; TEA, black solid line). (B) The ratio of the inactivation rate in the absence of QA (kinact−QA) to the inactivation rate in the presence of QA at its Ki value (kinact+QA) was plotted. Each bar
was generated from at least ﬁve recordings. The error bars indicate the SEM. Insert: hERG channel inactivation processes ﬁtted with a single exponential equation (controls, gray
dotted lines; QA blockers, black dotted lines).
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symmetric QAs
To examine the contributions of a cation-π interaction to hERG
channel blockade by QAs, the symmetric QA–benzene complexes
were chosen as a model system because different alkyl chains of a
head group in symmetric QAs have a different electron-donating
power, thus causing the difference in electron densities at a basic
nitrogen atom. The cation-π interaction energies of the symmetric
QA–benzene complexes were calculated at the Hartree–Fock level
with the 6–31 g(d,p) basis set using the Gaussian 03 program and
summarized in Table 2. The insert in Fig. 5A displays the geometry-
optimized TEA-benzene complex. For an efﬁcient interaction, benzene
in the complex is aligned parallel with the plane deﬁned by three
ethyl chains of TEA. Similarly, all other symmetric QA–benzene
complexes have such structures with different alkyl chain lengths. The
cation-π interaction energy was found to be decreased, approaching
an asymptotic value of −4.19 kcal/mol as the alkyl chain length in
head groups was increased (Fig. 5A). For the symmetric QA–benzene
complexes with a small head group, the cation-π interaction energy
was decreased gradually as the alkyl chain length was increased. This
indicates that an additional CH2 group in symmetric QA causes a
cation-π interaction to be less efﬁcient. When the alkyl chain length isTable 2
Summary of quantum calculations of cation-π interaction energies and the distances
between benzene and symmetric QAs (distanceBz–QA), and the relative cation-π binding
energies (ΔEb).
Symmetric QA Cation-π energy
(kcal/mol)
DistanceBz–QA
(nm)
ΔEb
(kcal/mol)
TMA −6.88 0.457 −1.59
TEA −5.29 0.482 0
TPA −4.60 0.504 0.69
TBA −4.36 0.502 0.93
TPnA −4.26 0.502 1.03
THxA −4.22 0.504 1.07
THpA −4.20 0.502 1.09
Cation-π interaction energies and the distances between benzene and symmetric
quaternary ammoniums (distanceBz–QA) were obtained from quantum calculations at
the Hartree–Fock level with the 6–31 g(d,p) basis set using the Gaussian 03 program.
Relative cation-π binding energies (ΔEb) were obtained using the cation-π interaction
energy of the TEA-benzene complex as a reference value.signiﬁcantly long, an additional CH2 group has a negligible effect on a
cation-π interaction because it cannot interact with benzene
effectively. In Fig. 5B, the cation-π binding energies between
symmetric QAs and benzene are plotted against the distance between
benzene and a nitrogen atom in symmetric QAs (distanceBz–QA). This
plot shows a strong correlation between the cation-π binding energy
and the intermolecular distance between symmetric QA and benzene.
For comparison, the experimentally obtained relative binding
energies (ΔΔG; ● and solid line) and the calculated relative cation-π
binding energies (ΔEb; □ and dotted line) were plotted against the
size of a head group in symmetric QAs, from tetrapropylammonium
(TPA) to THpA, that bind to a high-afﬁnity internal binding site
(Fig. 6). They exhibit the opposite trend of each other, implying that a
cation-π interaction is not a major contributor to hERG channel
inhibition by symmetric QA blockers that bind to the internal site.
4. Discussion
hERG channels suppress the cardiac arrhythmias by reducing extra
heart beats under the normal physiological conditions. Drug-induced
hERG channel inhibition could thus lead to the long QT syndrome, a
major cardiac toxic effect [9]. To avoid this potential harmful side
effect, hERG channel toxicity needs to be assessed in a timely and
efﬁcient fashion. Prediction of potential drug toxicity against hERG
channels using well-quantiﬁed data would thus be useful for
preclinical tests in drug discovery. In the present study, we attempted
to quantify the energetic contributions of hydrophobicity and cation-
π interactions to hERG channel inhibition using a series of QAs, whose
blockade of potassium channels has been thoroughly characterized.
Various QAs with different head and tail groups in size and length
were rigorously tested to systematically investigate their blocking
effects on hERG channels; for symmetric QA blockers, the size of head
group was varied from TMA to THpA while the length of tail group of
asymmetric QAs was changed from C6-TEA to C14-TEA. The inhibitory
constants were initially obtained using a pulse protocol that generates
hERG tail currents with automated patch clamp. Both head and tail
groups of QAs affected hERG channel blockade, and a distinct
structure–activity relationship of QA blockers was observed; more
hydrophobic QAs produced ~106-fold higher afﬁnity blockade than
TEA in their Ki values. Unlike blockers with a rigid structure, QAs with
long alkyl chains either in head or in tail are likely to be ﬂexible
Fig. 5. Ab initio calculations of cation-π interaction energies between symmetric QAs and benzene. (A) Cation-π interaction energies were plotted against the size of a head group in
symmetric QAs. Insert: geometry-optimized structure of the TEA-benzene complex obtained from quantum calculations at the Hartree–Fock level with the 6–31 g(d,p) basis set. (B)
Cation-π binding energies of the symmetric QA–benzene complexes were plotted against the distance between benzene and a nitrogen atom in symmetric QAs (distanceBz–QA).
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channels to maximize all favorable binding interactions, mostly van
der Waals hydrophobic interactions. As expected, however, these
enhanced blockade effects were gradually saturating, presumably due
to the limited space for favorable binding within the inner cavity.
Interestingly, THpA exhibited reduced blockade effects, which may
imply that the size of head group becomes more important when it is
signiﬁcantly big. A big head group of symmetric QAsmight obstruct its
accommodation in the binding site through steric hindrance.
Mutagenesis studies revealed that the pore region and the S6
segment of the inner cavity in hERG channel are crucial for drug
binding [19]. These two important binding sites, the pore region and
the S6 segment, may represent two distinct QA binding sites. The pore
region is likely to be a low-afﬁnity external binding site for small QAs
that cannot cross the cell membranewhile the S6 segment of the inner
cavity seems to be a high-afﬁnity internal binding site for more
hydrophobic QAs. Difference in binding afﬁnity of a series of QA
blockers studied could thus suggest their different accessibility to the
two distinct binding sites. Symmetric QAs with a relatively small head
group such as TMA or TEA would preferentially bind to the external
site in the pore region. Asymmetric QAs with a long carbon tail would
bind to the internal site in the inner cavity with higher afﬁnity. FourFig. 6. Comparison of the relative binding energy (ΔΔG) determined in automated
patch clamp to calculate relative cation-π binding energy (ΔEb). The experimentally
obtained ΔΔG values (● and solid line) and the calculated ΔEb values (□ and dotted
line) were plotted against the size of a head group in symmetric QAs that bind to the
high-afﬁnity internal site.alkyl chains of symmetric QAs with a big head group could act like a
long tail, thus also producing high-afﬁnity binding to the internal site.
To test this possibility, the effect of QA blockers on the hERG channel
inactivation process was examined because hERG channel inactiva-
tion is slowed by external QA blockers but not by internal QA blockers
[9]. Slowing of inactivation was observed in the presence of small QAs
such as TMA or TEA, which is consistent with the previous report that
externally applied TEA does not permeate the cell membrane but
binds to the outer mouth of hERG channel pore [9,20]. On the
contrary, QAs either with a bigger head group or with a longer tail
group than TEA did not inﬂuence the inactivation time course of hERG
channel, which suggests that QAs that aremore hydrophobic than TEA
do not interact with an external binding site but rather cross the
plasma membrane to act on the high-afﬁnity internal binding site.
A basic nitrogen atom in blockers has been reported to be critical
for high-afﬁnity blockade due to its positive charge [6], suggesting the
importance of a cation-π interaction. To examine the energetic
contributions of a cation-π interaction to hERG channel inhibition,
the relative cation-π binding energies (ΔEb) were calculated using ab
initio quantum mechanical methods and compared with the relative
binding energies (ΔΔG) obtained from the Ki values. The apparent
discrepancy between calculated ΔEb values and experimentally
obtained ΔΔG values indicates that a cation-π interaction is not a
major contributor to hERG channel blockade in the high-afﬁnity
internal binding site. This observation is consistent with a recent
docking model study [21], where a cation-π interaction appeared not
to be a main interaction in all test drugs with chemical diversity.
Moreover, there are two lines of structural evidence that support our
ﬁndings of the importance of hydrophobicity rather than a cation-π
interaction in hERG channel inhibition by QAs. The two aromatic
residues, Tyr652 and Phe656, in the S6 segment of the inner cavity are
known to be essential for high-afﬁnity drug binding to the internal
site and found only in hERG channel but not in other voltage-gated
potassium channels [19], implying their importance in promiscuous
hERG channel inhibition. Tyr652 and Phe656 have been proposed to
mediate cation-π interactions and hydrophobic interactions, respec-
tively [10,22]. Interestingly, it has been found that Phe656 is
important for binding of most of blockers while Tyr652 is crucial for
binding of only half of them [23], which may indicate that the
hydrophobic interactions of Phe656 are determinant factors for high-
afﬁnity blockade compared to the π-electron interactions of Tyr652.
Also, overall hydrophobicity of the inner cavity in hERG channels has
been suggested to be more important than several speciﬁc residues
1566 K.-H. Choi et al. / Biochimica et Biophysica Acta 1808 (2011) 1560–1566for blocker binding [19,24]. The signiﬁcance of hydrophobicity in
potassium channel inhibition has been also observed in voltage-gated
potassium channels expressed in giant squid axons; more hydropho-
bic QAs with a longer carbon chain produced stronger inhibition
[24,25]. A similar pattern was observed in Shaker potassium channels
as well [26].
In summary, the present work systemically evaluates hERG
channel inhibition by various QAs, suggesting that hydrophobicity of
QA blockers in the internal binding site is a dominant factor over a
cation-π interaction or steric hindrance in hERG channel blockade.
The signiﬁcance of hydrophobicity might explain why so many
structurally diverse drugs block hERG channels. In this study, QAs
were used to eliminate the contributions of other functional groups in
blockers than amine groups, which could be a potential caveat for
assessments of hERG channel liability of drugs. However, the detailed
characterization and quantitative analysis of hERG channel blockade
using systematically varied QAs may provide valuable information for
pre-screening in drug discovery, given the signiﬁcance of hERG
channels for cardiac liability tests.
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